The Oregon Health Authority (OHA) has asked all of the state’s vaccine providers to immediately stop administering the Johnson and Johnson vaccine, per the announcement from the U.S. CDC and FDA this morning. This is out of an abundance of caution as they review six cases of a rare and severe type of blood clot in women ages 18-48 after vaccination with the Johnson & Johnson vaccine.
The Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they were investigating unusual clots that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48; there was one death and all remained under investigation.
More than 6.8 million doses of the J&J vaccine have been given in the U.S., the vast majority with no or mild side effects.
In Baker County, a total of 431 doses of the J&J vaccine have been administered, according to the OHA.
Federally run mass vaccination sites will pause the use of the J&J shot, and states and other providers are expected to follow. The other two authorized vaccines, from Moderna and Pfizer, make up the vast share of COVID-19 shots administered in the U.S. and are not affected by the pause.